Arg-136, Glu-137, Arg-138 and Arg-139 are conserved in all sequences of the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Their role was studied by site-directed mutagenesis. All the mutations had little, if any, effect on fructose-2,6-bisphosphatase activity. Mutations of Arg-136 and Glu-137 into Ala caused only minor modifications of phosphofructo-2-kinase activity. In contrast, mutation of Arg-138 into Ala increased 280-fold the Km for fructose 6-phosphate of phosphofructo-2-kinase. Mutation of Arg-139 into Ala resulted in decreases in phosphofructo-2-kinase Vmax/Km for MgATP and fructose 6-phosphate 600-fold and 5000-fold respectively. Mutation of Arg-139 into Lys and Gln increased the Km of phosphofructo-2-kinase for MgATP (20-fold and 25-fold respectively) and for fructose 6-phosphate (8-fold and 13-fold), and the IC50 for MgADP (30-fold and 50-fold) and for magnesium citrate (7-fold and 25-fold). However, these two mutations did not affect nucleotide binding, as measured by quenching of intrinsic fluorescence. The changes in kinetic properties induced by mutations could not be attributed to structural changes. It is proposed that Arg-138 is involved in fructose 6-phosphate binding and that Arg-139 is probably involved in the stabilization of the transition state and so participates in catalysis.
Skip Nav Destination
Article navigation
February 1997
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Research Article|
February 01 1997
Mutagenesis of charged residues in a conserved sequence in the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
Luc BERTRAND;
Luc BERTRAND
*Facultés Universitaires Notre-Dame de la Paix, Department of Biology, rue de Bruxelles, 61, B-5000 Namur, Belgium
†Hormone and Metabolic Research Unit, University of Louvain Medical School, and International Institute of Cellular and Molecular Pathology, Avenue Hippocrate, 75, B-1200 Brussels, Belgium
Search for other works by this author on:
Didier VERTOMMEN;
Didier VERTOMMEN
†Hormone and Metabolic Research Unit, University of Louvain Medical School, and International Institute of Cellular and Molecular Pathology, Avenue Hippocrate, 75, B-1200 Brussels, Belgium
Search for other works by this author on:
Ernest FEYTMANS;
Ernest FEYTMANS
*Facultés Universitaires Notre-Dame de la Paix, Department of Biology, rue de Bruxelles, 61, B-5000 Namur, Belgium
Search for other works by this author on:
Attilio Di PIETRO;
Attilio Di PIETRO
‡Institut de Biologie et de Chimie des Protéines, Centre National de la Recherche Scientifique, Passage du Vercors, F-69367 Lyon cedex 07, France
Search for other works by this author on:
Mark H. RIDER;
Mark H. RIDER
†Hormone and Metabolic Research Unit, University of Louvain Medical School, and International Institute of Cellular and Molecular Pathology, Avenue Hippocrate, 75, B-1200 Brussels, Belgium
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 26 1996
Revision Received:
August 22 1996
Accepted:
September 20 1996
Online ISSN: 1470-8728
Print ISSN: 0264-6021
The Biochemical Society, London © 1997
1997
Biochem J (1997) 321 (3): 609–614.
Article history
Received:
June 26 1996
Revision Received:
August 22 1996
Accepted:
September 20 1996
Connected Content
Citation
Luc BERTRAND, Didier VERTOMMEN, Ernest FEYTMANS, Attilio Di PIETRO, Mark H. RIDER, Louis HUE; Mutagenesis of charged residues in a conserved sequence in the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Biochem J 1 February 1997; 321 (3): 609–614. doi: https://doi.org/10.1042/bj3210609
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.